Par Drugs and Chemicals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was INR 956.4 million compared to INR 957.49 million a year ago. Revenue was INR 958.83 million compared to INR 959.87 million a year ago. Net income was INR 145.01 million compared to INR 113.34 million a year ago. Basic earnings per share from continuing operations was INR 11.78 compared to INR 9.21 a year ago. Diluted earnings per share from continuing operations was INR 11.78 compared to INR 9.21 a year ago.